Company
Nanoform Finland Oyj
Headquarters: Helsinki, Finland
Employees: 125
CEO: Prof. Edward Olof Haeggstrom
Market Cap
€149.8 Million
EUR as of July 1, 2024
US$160.9 Million
Nanoform Finland Oyj Categories
Finland Healthcare BiotechnologyFinland Healthcare Finland Biotechnology
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $622.07 B |
| Vertex Pharmaceuticals Incorporated | $121.36 B |
| Regeneron Pharmaceuticals, Inc. | $115.11 B |
| CSL Limited | $95.75 B |
| Marinomed Biotech AG | $75.67 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Detailed Description
Nanoform Finland Oyj provides nanotechnology and drug particle engineering services for the pharmaceutical industry in Finland and internationally. The company provides nanoparticle production services using its proprietary controlled expansion of supercritical solutions technology that enables clients in the creation of active pharmaceutical ingredients nanoparticles directly from solution. The company was founded in 2008 and is headquartered in Helsinki, Finland.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
Nanoform Finland Oyj has the following listings and related stock indices.
Stock: OMXH: NANOFH wb_incandescent
Stock: FSX: 4YL wb_incandescent